Cargando…
LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22
Doxorubicin (Dox) is one of the most commonly used chemotherapeutic drugs for osteosarcoma (OS) treatment. In the present study, we attempted to investigate the mechanism by which Sox2OT-V7 dysregulation affects Dox chemoresistance to provide a novel experimental basis for developing neoadjuvant the...
Autores principales: | Zhu, Kewei, Yuan, Yang, Wen, Jie, Chen, Ding, Zhu, Weihong, Ouyang, Zhengxiao, Wang, Wanchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202483/ https://www.ncbi.nlm.nih.gov/pubmed/32302291 http://dx.doi.org/10.18632/aging.103004 |
Ejemplares similares
-
Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p
por: Ma, Xiao-Long, et al.
Publicado: (2021) -
SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition
por: Wang, Wanchun, et al.
Publicado: (2018) -
The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer
por: Bolayırlı, Ibrahim Murat, et al.
Publicado: (2022) -
Involvement of miR-142 and miR-155 in Non-Infectious Complications of CVID
por: Amato, Giuliana, et al.
Publicado: (2020) -
miR-142 suppresses proliferation and induces apoptosis of osteosarcoma cells by upregulating Rb
por: Gao, Yan-Fang, et al.
Publicado: (2018)